Duration of antibiotic treatment in hospitalized patients with complicated skin and skin structure infections (cSSSI): Findings from a clinical study comparing tigecycline and vancomycin/aztreonam

被引：0
|
作者：
Yu, H
Mallick, R
Weber, DJ
机构：
[1] Wyeth Res, Collegeville, PA USA
[2] Univ N Carolina, Chapel Hill, NC USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62786-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：305 / 305
页数：1
相关论文
共 50 条
  • [1] Tigecycline as effective as vancomycin plus aztreonam in the treatment of complicated skin and skin structure infections: Experience in Latin America
    Campos B, M. Isabel
    Curcio J, Daniel
    Seas R, Carlos
    Jasovich, Abel
    Northland G, Rebeca
    Arathoon P, Eduardo
    Rodriguez N, Eduardo
    Ellis-Grosse J, Evelyn
    Loh, Evan
    Cooper H, Angel
    REVISTA CHILENA DE INFECTOLOGIA, 2009, 26 : S23 - S31
  • [2] Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan
    Chuang, Yin-Ching
    Chang, Chia-Ming
    Aradhya, Sacchidanand
    Nagari, Bheerappa
    Poi, Vishwanath
    Dartois, Nathalie
    Jouve, Sylvie
    Cooper, Angel
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2011, 44 (02) : 116 - 124
  • [3] Risk factors for prolonged hospitalization in treatment of complicated skin infections: evidence from a randomized clinical trial comparing tigecycline with vancomycin/aztreonam.
    Mallick, R
    Solomon, S
    PHARMACOTHERAPY, 2005, 25 (03): : 470 - 470
  • [4] ASSESSING OUTCOMES WITH CEFTAROLINE TREATMENT COMPARED WITH STANDARD OF CARE AMONG HOSPITALIZED PATIENTS WITH COMPLICATED SKIN AND SKIN-STRUCTURE INFECTIONS (CSSSI)
    Karve, S.
    Hackett, J.
    Levinson, J.
    VALUE IN HEALTH, 2015, 18 (03) : A229 - A230
  • [5] Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections
    Edelsberg, John
    Berger, Ariel
    Weber, David J.
    Mallick, Rajiv
    Kuznik, Andreas
    Oster, Gerry
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (02): : 160 - 169
  • [6] Safety and efficacy of tigecycline in treatment of skin and skin structure infections: Results of a double-blind phase 3 comparison study with vancomycin-aztreonam
    Breedt, J
    Teras, J
    Gardovskis, J
    Maritz, FJ
    Vaasna, T
    Ross, DP
    Gioud-Paquet, M
    Dartois, N
    Ellis-Grosse, EJ
    Loh, E
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) : 4658 - 4666
  • [7] Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial
    Sacchidanand, S
    Penn, RL
    Embil, JM
    Campos, ME
    Curcio, D
    Ellis-Grosse, E
    Loh, E
    Rose, G
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2005, 9 (05) : 251 - 261
  • [8] Daptomycin versus vancomycin for complicated skin and skin structure infections: Clinical and economic outcomes
    Davis, Susan L.
    McKinnon, Peggy S.
    Hall, Levi M.
    Delgado, George, Jr.
    Rose, Warren
    Wilson, Robert E.
    Rybak, MichaelJ.
    PHARMACOTHERAPY, 2007, 27 (12): : 1611 - 1618
  • [9] RANDOMIZED CONTROLLED NONINFERIORITY TRIAL COMPARING DAPTOMYCIN TO VANCOMYCIN FOR THE TREATMENT OF COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS IN AN OBSERVATION UNIT
    Shaw, George J.
    Meunier, Jason M.
    Korfhagen, Joseph
    Wayne, Beth
    Hart, Kimberly
    Lindsell, Christopher J.
    Fermann, Gregory
    JOURNAL OF EMERGENCY MEDICINE, 2015, 49 (06): : 928 - 936
  • [10] Overview of Tigecycline Efficacy and Safety in the Treatment of Complicated Skin and Skin Structure Infections - A European Perspective
    Teras, J.
    Gardovskis, J.
    Vaasna, T.
    Kupcs, U.
    Pupelis, G.
    Dukart, G.
    Dartois, N.
    Jouve, S.
    Cooper, A.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 : 20 - 27
12345